Real-world Study of StimLabs Human Placental Membrane Tissue to Treat Hard-to-Heal Wounds

Completed

Conditions studied: Chronic Wounds, Diabetic Ulcers

In brief

This is a retrospective, multi-center observational study to assess real-world outcomes of StimLabs human placental membrane tissue used in the treatment of hard-to-heal wounds, including chronic ulcers, diabetic foot ulcers (DFUs), and venous leg ulcers (VLUs). The collection of retrospective real-world data provides a broad range of experiences related to patient healthcare and treatment.

Key facts

Study ID

NCT07215741

Run by

StimLabs

People needed

23

Starts

2025-09-01

Expected to finish

2025-11-01

Last updated by the study team

2026-06-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Consecutive diabetic subjects that received a Relese product application during treatment between May 2023 and April 2025.

You may not qualify if…

• Subjects not receiving an initial Relese application during treatment.

Where it is running

• Cypress Wound Care — Oklahoma City, Oklahoma, United States
• Premier Foot & Ankle — Denison, Texas, United States
• Premier Foot & Ankle — Frisco, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.